Comparative safety and efficacy of different corticosteroid regimens in boys with Duchenne muscular dystrophy: results of a randomized controlled trial

被引：0
|
作者：
Guglieri, M. [1 ]
McDermott, M. [2 ]
Bushby, K. [1 ]
Hart, K. [2 ]
Tawil, R. [2 ]
Martens, W. [2 ]
Herr, B. [2 ]
McColl, E. [1 ]
Speed, C. [1 ]
Wilkinson, J. [1 ]
Kirschner, J. [3 ]
King, W. [4 ]
Eagle, M. [1 ]
Brown, M. [2 ]
Willis, W. [5 ]
Griggs, R. [2 ]
机构：
[1] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England
[2] Univ Rochester, Med Ctr, Rochester, NY 14627 USA
[3] Univ Hosp Freiburg, Freiburg, Germany
[4] Ohio State Univ, Columbus, OH 43210 USA
[5] RJAH Hosp NHS Fdn Trust, Oswestry, Shrops, England
来源：
NEUROMUSCULAR DISORDERS | 2022年 / 32卷
关键词：
D O I：
10.1016/j.nmd.2022.07.238
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.122
引用
收藏
页码：S99 / S99
页数：1
相关论文
共 50 条
  • [1] Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy A Randomized Clinical Trial
    Guglieri, Michela
    Bushby, Kate
    McDermott, Michael P.
    Hart, Kimberly A.
    Tawil, Rabi
    Martens, William B.
    Herr, Barbara E.
    McColl, Elaine
    Speed, Chris
    Wilkinson, Jennifer
    Kirschner, Janbernd
    King, Wendy M.
    Eagle, Michelle
    Brown, Mary W.
    Willis, Tracey
    Griggs, Robert C.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (15): : 1456 - 1468
  • [2] Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy A Randomized Clinical Trial
    Guglieri, Michela
    Clemens, Paula R.
    Perlman, Seth J.
    Smith, Edward C.
    Horrocks, Iain
    Finkel, Richard S.
    Mah, Jean K.
    Deconinck, Nicolas
    Goemans, Nathalie
    Haberlova, Jana
    Straub, Volker
    Mengle-Gaw, Laurel J.
    Schwartz, Benjamin D.
    Harper, Amy D.
    Shieh, Perry B.
    De Waele, Liesbeth
    Castro, Diana
    Yang, Michelle L.
    Ryan, Monique M.
    McDonald, Craig M.
    Tulinius, Mar
    Webster, Richard
    McMillan, Hugh J.
    Kuntz, Nancy L.
    Rao, Vashmi K.
    Baranello, Giovanni
    Spinty, Stefan
    Childs, Anne-Marie
    Sbrocchi, Annie M.
    Selby, Kathryn A.
    Monduy, Migvis
    Nevo, Yoram
    Vilchez-Padilla, Juan J.
    Nascimento-Osorio, Andres
    Niks, Erik H.
    de Groot, Imelda J. M.
    Katsalouli, Marina
    James, Meredith K.
    van den Anker, Johannes
    Damsker, Jesse M.
    Ahmet, Alexandra
    Ward, Leanne M.
    Jaros, Mark
    Shale, Phil
    Dang, Utkarsh J.
    Hoffman, Eric P.
    JAMA NEUROLOGY, 2022, 79 (10) : 1005 - 1014
  • [3] Myoglobinuria in boys with Duchenne muscular dystrophy on corticosteroid therapy
    Garrood, P.
    Eagle, M.
    Jardine, P. E.
    Bushby, K.
    Straub, V.
    NEUROMUSCULAR DISORDERS, 2008, 18 (01) : 71 - 73
  • [4] Randomized, Double-blind Controlled Trial Assessing The Dose Response And Safety Of Deflazacort In Boys With Duchenne Muscular Dystrophy
    Reddy, Chaithanya
    Suthar, Renu
    Patil, Amol
    Saxena, Somya
    Saini, Arushi G.
    Sankhyan, Naveen
    Sankhyan, Naveen
    NEUROLOGY, 2021, 96 (15)
  • [5] Assisted bicycle training delays physical deterioration in boys with Duchenne muscular dystrophy: Results of the randomized controlled trial "no use is disuse"
    Jansen, M.
    van Alfen, N.
    Geurts, A. C. H.
    de Groot, I. J. M.
    NEUROMUSCULAR DISORDERS, 2011, 21 (9-10) : 658 - 658
  • [6] Efficacy and Safety of Vamorolone Over 48 Weeks in Boys With Duchenne Muscular Dystrophy
    Dang, Utkarsh J.
    Damsker, Jesse M.
    Guglieri, Michela
    Clemens, Paula R.
    Perlman, Seth J.
    Smith, Edward C.
    Horrocks, Iain
    Finkel, Richard S.
    Mah, Jean K.
    Deconinck, Nicolas
    Goemans, Nathalie M.
    Haberlova, Jana
    Straub, Volker
    Mengle-Gaw, Laurel
    Schwartz, Benjamin D.
    Harper, Amy
    Shieh, Perry B.
    De Waele, Liesbeth
    Castro, Diana
    Yang, Michele L.
    Ryan, Monique M.
    McDonald, Craig M.
    Tulinius, Mar
    Webster, Richard I.
    Mcmillan, Hugh J.
    Kuntz, Nancy
    Rao, Vamshi K.
    Baranello, Giovanni
    Spinty, Stefan
    Childs, Anne-Marie
    Sbrocchi, Annie M.
    Selby, Kathryn A.
    Monduy, Migvis
    Nevo, Yoram
    Vilchez, Juan J.
    Nascimento-Osorio, Andres
    Niks, Erik H.
    De Groot, Imelda J. M.
    Katsalouli, Marina
    van den Anker, John N.
    Ward, Leanne M.
    Leinonen, Mika
    D'Alessandro, Andrea L.
    Hoffman, Eric P.
    NEUROLOGY, 2024, 102 (05)
  • [7] Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping A Phase 2 Randomized Clinical Trial
    Clemens, Paula R.
    Rao, Vamshi K.
    Connolly, Anne M.
    Harper, Amy D.
    Mah, Jean K.
    Smith, Edward C.
    McDonald, Craig M.
    Zaidman, Craig M.
    Morgenroth, Lauren P.
    Osaki, Hironori
    Satou, Youhei
    Yamashita, Taishi
    Hoffman, Eric P.
    JAMA NEUROLOGY, 2020, 77 (08) : 982 - 991
  • [8] Comparison of brain volume reduction in boys with Duchenne muscular dystrophy treated with different corticosteroid regimes
    Geuens, S.
    Van Dessel, J.
    Lemiere, J.
    Niks, E.
    Goemans, N.
    Kan, H.
    De Waele, L.
    Doorenweerd, N.
    NEUROMUSCULAR DISORDERS, 2022, 32 : S68 - S68
  • [9] Vertebral fractures in corticosteroid-treated boys with Duchenne muscular dystrophy
    Ambegaonkar, G. P.
    Kinali, M.
    Muntoni, F.
    Robb, S. A.
    Manzur, A. Y.
    NEUROMUSCULAR DISORDERS, 2008, 18 (9-10) : 825 - 826
  • [10] A randomized trial of deflazacort and prednisone in Duchenne muscular dystrophy: Efficacy and toxicity
    Brooke, MH
    NEUROLOGY, 1996, 46 (02) : 68001 - 68001
12345